05/03
Headlines

NASDAQ:IDIX

Active Movers: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Groupon Inc (NASDAQ:GRPN), Twenty-First Century Fox Inc (NASDAQ:FOXA), Sirius XM Holdings Inc. (NASDAQ:SIRI), DryShips Inc. (NASDAQ:DRYS)

Mark DeFrance03 mins

The U.S. drug maker offered Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) shareholders $24.50 a share, or $3.85 billion, for the developer of hepatitis C drugs. That’s almost quadruple the stock’s average unaffected price over the previous 20 days, the highest premium on record for any health care deal of at least $100 million, according to data compiled…

Read More

Active Movers: Facebook Inc (NASDAQ:FB), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Sirius XM Holdings Inc. (NASDAQ:SIRI), General Electric Company (NYSE:GE)

Jason Knox02 mins

Mark Zuckerberg and other members of Facebook Inc (NASDAQ:FB)’s board have been sued by a shareholder who claimed a policy letting them annually award directors more than $150 million of stock each if they choose is unreasonably generous. Facebook Inc (NASDAQ:FB) stock performance was 0.61% in last session and finished the day at $62.88. Traded…

Read More

Biotech unusual volume stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), BioDelivery Sciences International (NASDAQ:BDSI), ImmunoCellular Therapeutics (NYSEMKT:IMUC), Anika Therapeutics (NASDAQ:ANIK)

Jason Knox03 mins

AbbVie may now consider a takeover of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), a $411 million company, to expand in that market, Redmond said. Shares of Achillion rallied (ACHN:US) as much as 67 percent yesterday. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was 47.57% in last session and finished the day at $4.25. Traded volume was 47.79million shares…

Read More